Gauri G. Nagargoje

Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412

Grzegorz S. Nowakowski, Fangxin Hong, David W. Scott et al. · Journal of Clinical Oncology · 2021 · 109 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03)

Lynne I. Wagner, Fengmin Zhao, Paul E. Goss et al. · Breast Cancer Research and Treatment · 2018 · 95 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

The Use of Valeriana officinalis (Valerian) in Improving Sleep in Patients Who Are Undergoing Treatment for Cancer: A Phase III Randomized, Placebo-Controlled, Double-Blind Study (NCCTG Trial, N01C5)

Debra L. Barton, Brent A. Bauer, Dennis F. Moore et al. · The Journal of Supportive Oncology · 2011 · 78 citations

Medicine, Oncology, Pharmacotherapy +14

ADDITION OF LENALIDOMIDE TO R‐CHOP (R2CHOP) IMPROVES OUTCOMES IN NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): FIRST REPORT OF ECOG‐ACRIN1412 A RANDOMIZED PHASE 2 US INTERGROUP STUDY OF R2CHOP VS R‐CHOP

Grzegorz S. Nowakowski, Fangxin Hong, David W. Scott et al. · Hematological Oncology · 2019 · 35 citations

Medicine, Hematology, Oncology +16